Skip to main content
Premium Trial:

Request an Annual Quote

Patrick Finn

Twist Bioscience named Patrick Finn vice president of sales and marketing. He joins the company as it prepares to launch its synthetic biology platform services this year. Finn was previously at Enzymatics, where he was VP of sales and marketing. Prior to that, he was director of business development at Agilent Technologies, director of product development at Beckman Coulter Molecular Diagnostics, and held various positions at Invitrogen and GE Healthcare/Amersham International.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.